FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   FW Oak Hill Accretive Healthcare Investors, L.P. 2. Date of Event Requiring Statement (Month/Day/Year) 05/19/2010 3. Issuer Name and Ticker or Trading Symbol Accretive Health, Inc. [AH] (Last) (First) (Middle) 201 MAIN STREET, SUITE 3100 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) FORT WORTH, TX 76102 6. Individual or Joint/Group Filing(Check Applicable Line) ___ Form filed by One Reporting Person _X_ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series A Convertible Preferred Stock	  (1)	  (1)	Common Stock	15,947,601 (1)	$ (1)	D (3)	Â
Series D Convertible Preferred Stock	  (2)	  (2)	Common Stock	1,477,161 (2)	$ (2)	D (3)	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
FW Oak Hill Accretive Healthcare Investors, L.P. 201 MAIN STREET SUITE 3100 FORT WORTH, TX 76102	Â	  X	Â	Â
GROUP VI 31 LLC 201 MAIN STREET SUITE 3100 FORT WORTH, TX 76102	Â	  X	Â	Â
CRANDALL J TAYLOR 2775 SAND HILL ROAD SUITE 220 MENLO PARK, CA 94025	Â	  X	Â	Â

Signatures

J. Taylor Crandall, President of Group VI 31, LLC, general partner of FW Oak Hill Accretive Healthcare Investors, L.P.		05/19/2010
**Signature of Reporting Person		Date
J. Taylor Crandall, President of Group VI 31, LLC		05/19/2010
**Signature of Reporting Person		Date
J. Taylor Crandall		05/19/2010
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The Series A Convertible Preferred Stock is immediately convertible into the Issuer's common stock on a 1,201.5069 for one basis and has no expiration date. Each share of Series A Convertible Preferred Stock will automatically convert into shares of common stock immediately prior to the closing of the Issuer's initial public offering.
(2)	The Series D Convertible Preferred Stock is immediately convertible into the Issuer's common stock on a 3.92 for one basis and has no expiration date. Each share of Series D Convertible Preferred Stock will automatically convert into shares of common stock immediately prior to the closing of the Issuer's initial public offering.
(3)	Group VI 31, LLC ("Group VI 31") is the sole general partner of FW Oak Hill Accretive Healthcare Investors, L.P. (the "Oak Hill Partnership"), which is the direct holder of the shares reported herein. J. Taylor Crandall ("Crandall") is the sole member and President of Group VI 31 and a limited partner of the Oak Hill Partnership. Crandall and Group VI 31 disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest therein. The shares reported herein do not include 402,157 shares of common stock that the Oak Hill Partnership has elected to receive in satisfaction of the liquidation preference payment that will be paid to the holders of the Issuer's preferred stock upon the closing of its initial public offering, assuming an initial public offering price of $15.00 per share.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.